203 related articles for article (PubMed ID: 11550799)
1. Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology.
Pshezhetsky AV; Ashmarina M
Prog Nucleic Acid Res Mol Biol; 2001; 69():81-114. PubMed ID: 11550799
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.
Callahan JW
Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal high molecular weight multienzyme complex.
Ostrowska H; Krukowska K; Kalinowska J; Orłowska M; Lengiewicz I
Cell Mol Biol Lett; 2003; 8(1):19-24. PubMed ID: 12655352
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal multienzyme complex: pros and cons of working together.
Bonten EJ; Annunziata I; d'Azzo A
Cell Mol Life Sci; 2014 Jun; 71(11):2017-32. PubMed ID: 24337808
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin A/protective protein: an unusual lysosomal multifunctional protein.
Hiraiwa M
Cell Mol Life Sci; 1999 Dec; 56(11-12):894-907. PubMed ID: 11212324
[TBL] [Abstract][Full Text] [Related]
6. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
Kwak JE; Son MY; Son YS; Son MJ; Cho YS
Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal multienzymatic complex-related diseases: a genetic study among Portuguese patients.
Coutinho MF; Lacerda L; Macedo-Ribeiro S; Baptista E; Ribeiro H; Prata MJ; Alves S
Clin Genet; 2012 Apr; 81(4):379-93. PubMed ID: 21214877
[TBL] [Abstract][Full Text] [Related]
9. Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate.
Pshezhetsky AV; Potier M
J Biol Chem; 1996 Nov; 271(45):28359-65. PubMed ID: 8910459
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
[TBL] [Abstract][Full Text] [Related]
11. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
[TBL] [Abstract][Full Text] [Related]
12. Molecular form and subcellular distribution of acid beta-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis.
Takiyama N; Itoh K; Shimmoto M; Nishimoto J; Inui K; Sakuraba H; Suzuki Y
Brain Dev; 1997 Mar; 19(2):126-30. PubMed ID: 9105659
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.
d'Azzo A; Bonten E
Biochem Soc Trans; 2010 Dec; 38(6):1453-7. PubMed ID: 21118106
[TBL] [Abstract][Full Text] [Related]
14. Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis.
Caciotti A; Donati MA; Boneh A; d'Azzo A; Federico A; Parini R; Antuzzi D; Bardelli T; Nosi D; Kimonis V; Zammarchi E; Morrone A
Hum Mutat; 2005 Mar; 25(3):285-92. PubMed ID: 15714521
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular heterogeneity in hereditary beta-galactosidase deficiency.
Suzuki Y; Sakuraba H; Oshima A; Yoshida K; Shimmoto M; Takano T; Fukuhara Y
Dev Neurosci; 1991; 13(4-5):299-303. PubMed ID: 1817034
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism.
Rudenko G; Bonten E; d'Azzo A; Hol WG
Structure; 1995 Nov; 3(11):1249-59. PubMed ID: 8591035
[TBL] [Abstract][Full Text] [Related]
17. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
Hinek A; Zhang S; Smith AC; Callahan JW
Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.
Ohto U; Usui K; Ochi T; Yuki K; Satow Y; Shimizu T
J Biol Chem; 2012 Jan; 287(3):1801-12. PubMed ID: 22128166
[TBL] [Abstract][Full Text] [Related]
19. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients.
Santamaria R; Chabás A; Callahan JW; Grinberg D; Vilageliu L
J Lipid Res; 2007 Oct; 48(10):2275-82. PubMed ID: 17664528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
